ArticleESMO open2023

Long term activity of vemurafenib in cancers with BRAF mutations: the ACSE basket study for advanced cancers other than BRAF

J Y Blay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.